Breaking News Instant updates and real-time market news.

FOLD

Amicus

$13.28

-0.39 (-2.85%)

, MNKD

MannKind

$2.23

0.19 (9.31%)

09:40
09/13/17
09/13
09:40
09/13/17
09:40

Unusually active option classes on open September 13th

Unusual total active option classes on open include: Amicus (FOLD), MannKind (MNKD), Nordstrom (JWN), Altria Group (MO), McDonald's (MCD), Western Digital (WDC), Chesapeake (CHK), Apple (AAPL), Macy's (M), and Vale (VALE).

FOLD

Amicus

$13.28

-0.39 (-2.85%)

MNKD

MannKind

$2.23

0.19 (9.31%)

JWN

Nordstrom

MO

Altria Group

MCD

McDonald's

WDC

Western Digital

$88.78

1.4 (1.60%)

CHK

Chesapeake

AAPL

Apple

$160.86

-0.64 (-0.40%)

M

Macy's

VALE

Vale

  • 13

    Sep

  • 19

    Sep

  • 25

    Sep

  • 25

    Sep

  • 02

    Oct

FOLD Amicus
$13.28

-0.39 (-2.85%)

08/17/17
JPMS
08/17/17
NO CHANGE
JPMS
JPMorgan lists top SMID Biotechnology picks following Q2 results
Analysts at JPMorgan continue think selectively remains important in the small-to-mid cap Biotechnology space. The analysts listed their favorite ideas in "five key buckets." Amicus (FOLD) is the top long-term pick, Ironwood (IRWD) is the top pick among relative underperformers, Otonomy (OTIC) is the top play for a clinical/binary event, Sarepta (SRPT) is the name to take advantage of the recent share weakness, and Ignyta (RXDX) is the "underfollowed/undervalued" favorite, according to JPMorgan's Biotech team.
07/11/17
COWN
07/11/17
NO CHANGE
Target $16
COWN
Outperform
Amicus price target raised to $16 from $10 at Cowen
06/05/17
JPMS
06/05/17
NO CHANGE
Target $13
JPMS
Overweight
Amicus shares can double on positive zorblisa data, says JPMorgan
JPMorgan analyst Anupam Rama believes investor sentiment remains very low on Amicus Therapeutics' Phase 3 readout of zorblisa. The Phase 3 Essence data for the treatment of epidermolysis bullosa are expected in Q3. The trial is "high-risk/high-reward," Rama tells investors in a research note. The analyst says he's taking a "very conservative" approach for zorblisa with $300M in peak sales and a 40% probability of success. Rama believes the stock at current levels reflects no value for zorblisa. On positive data, Amicus shares have the potential to double, Rama writes. On negative data, he sees only "sentiment based" downside of 5%-15%. The analyst keeps an Overweight rating on Amicus with a $13 price target.
07/11/17
JPMS
07/11/17
NO CHANGE
JPMS
Overweight
Amicus could be up 15%-20% on today's news, says JPMorgan
JPMorgan analyst Anupam Rama believes shares of Amicus Therapeutics could be up 15%-20% today on news of the FDA confirming that the regulatory filing for migalastat for the treatment of Fabry can now be submitted. The stock in premarket trading is up 31% to $13.45. The analyst estimates that a U.S. launch of migalastat is now moved up by two years. Rama has an Overweight rating on Amicus.
MNKD MannKind
$2.23

0.19 (9.31%)

05/11/17
PIPR
05/11/17
NO CHANGE
Target $0.54
PIPR
Underweight
MannKind sales of Afrezza remain slow, says Piper Jaffray
Piper Jaffray analyst Joshua Schimmer says sales of MannKind's Afrezza "failed to meaningfully inflect" in Q1 despite new commercialization initiatives. The company continues to drain its cash, Schimmer tells investors in a post-earnings research note. He reiterates an Underweight rating on MannKind with a 54c price target.
08/11/17
MAXM
08/11/17
INITIATION
Target $4
MAXM
Buy
MannKind initiated with a Buy at Maxim
Maxim analyst Jason Kolbert started MannKind with a Buy rating and $4 price target, stating that the relaunch of Afrezza is building traction. A "conservative" 5% share of the U.S. insulin market is a $350M opportunity for Afrezza, added Kolbert.
08/11/17
08/11/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Strongbridge Biopharma (SBBP) initiated with an Outperform at Oppenheimer. 2. Discovery (DISCA) initiated with a Neutral at Piper Jaffray. 3. MannKind (MNKD) initiated with a Buy at Maxim. 4. Veritone (VERI) initiated with a Buy at Roth Capital. 5. Esperion (ESPR) initiated with a Neutral at BofA/Merrill. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
JWN Nordstrom

06/21/17
GDHS
06/21/17
NO CHANGE
GDHS
Nike-Amazon pact yet another department store headwind, says Gordon Haskett
Gordon Haskett analyst noted the reports of Nike (NKE) nearing a deal to sell directly on Amazon (AMZN), which he said wouldn't impact trends overnight but would represent another headwind for department stores, particularly J.C. Penney (JCP) and Kohl's (KSS), where the brand has a larger penetration than at Macy's (M) and Nordstrom (JWN). He keeps an Accumulate rating on Nordstrom, a Hold rating on Macy's and Reduce rating on both J.C. Penney and Kohl's.
06/14/17
CLVD
06/14/17
NO CHANGE
CLVD
Nordstrom Q2 comps likely trending below consensus at Cleveland Research
09/13/17
GDHS
09/13/17
DOWNGRADE
GDHS
Hold
Nordstrom downgraded to Hold from Accumulate at Gordon Haskett
07/14/17
JPMS
07/14/17
NO CHANGE
JPMS
Underweight
JPMorgan keeps Underweight on Nordstrom after management meetings
JPMorgan analyst Matthew Boss keeps an Underweight rating on Nordstrom (JWN) after meeting management at the company's headquarters. Management would not comment on their evaluation of strategic alternatives and the meeting was reshuffled to exclude members of the Nordstrom family while incoming CFO Anne Bramman attended but did not actively participate, Boss tells investors in a research note. The analyst views the company's EBITDA roadmap as "increasingly uncertain" with a greater emphasis on fashion to differentiate mix versus Amazon.com (AMZN) and rising costs of customer acquisition. He believes the retailer's fundamental multi-year risk profile is elevated.
MO Altria Group

08/30/17
MSCO
08/30/17
NO CHANGE
MSCO
Overweight
British American Tobacco recent weakness appears overdone, says Morgan Stanley
Morgan Stanley analyst Matthew Grainger said he views some degree of weakness in U.S. and European tobacco stocks since "FDA Friday" - when the agency announced plan to pursue reduced nicotine content in cigarettes - as warranted, but he views the impact on British American Tobacco (BTI) as being overstated by the stock's 11% pullback. For Altria Group (MO), which is down 14% since that day, he sees the move as having returned the stock to appropriate valuation levels, he added. Grainger lowered his price target for Altria to $65 from $68, kept his Philip Morris (PM) price target of $120 unchanged and maintains his British American target at GBP60.
07/31/17
07/31/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Altria Group (MO) upgraded to Sector Perform from Underperform at RBC Capital with analyst Nik Modi saying he believes the FDA's tobacco announcement on Friday was "very much in line" with industry expectations despite the surprise to investors. 2. American Airlines (AAL) upgraded to Outperform from Market Perform at Cowen. 3. Baidu (BIDU) upgraded to Buy from Neutral at Nomura Instinet with analyst Jialong Shi-NIHK citing accelerating revenue momentum driven by news feed ads and an undervalued video business. 4. Wells Fargo (WFC) upgraded to Market Perform from Underperform at BMO Capital with analyst James Fotheringham citing valuation. The firm also ended its pair trade call of going long Citi (C) and short Wells Fargo. 5. GoPro (GPRO) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Yuuji Anderson saying valuation better reflects efforts to driver better product cycles through software improvements. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/31/17
07/31/17
UPGRADE
Target $62

Sector Perform
Altria Group upgraded to Sector Perform at RBC Capital
As previously reported, RBC Capital analyst Nik Modi upgraded Altria Group to Sector Perform from Underperform, as he believes the FDA's tobacco announcement on Friday was "very much in line" with industry expectations despite the surprise to investors. Modi, who still thinks tobacco stocks can perform despite major overhangs, keeps a $62 price target on Altria.
07/31/17
WELS
07/31/17
NO CHANGE
WELS
Altria Group still likely to be acquired after FDA news,says Wells Fargo
After the FDA announced a new approach towards nicotine Friday, Wells Fargo expects Altria (MO) to be "a big beneficiary" of the approach, since it will spur much higher purchases of reduced-risk products and smokeless cigarettes, leading to share gains for Altria, according to the firm. Wells believes that the FDA's announcement may increase the value of Altria to "close to $90 per share" from $80 per share previously, and it continues to expect the company to be acquired by Philip Morris (PM). Wells thinks that tobacco stocks could experience an "overhang in the near-term," but it says the news "could be positive" for the sector over the longer term, as it thinks the large tobacco companies will ultimately benefit from the change in consumption trends. British American Tobacco (BTI) is another publicly traded company in the sector.
MCD McDonald's

07/26/17
BARD
07/26/17
NO CHANGE
Target $170
BARD
Outperform
McDonald's price target raised to $170 from $164 at Baird
Baird analyst David Tarantino raised his estimates on McDonald's following Q2 results. The analyst said based on the fundamental outlook, the risk/reward on the stock looks favorable. He cited better than expected comps and positive traffic across all segments. Tarantino reiterated his Outperform rating and raised his price target to $170 from $164 on McDonald's shares.
09/12/17
MSCN
09/12/17
NO CHANGE
MSCN
MScience establishes McDonald's Q3 US sales estimate below consensus
Shares of McDonald's are trading lower following MScience establishing a Q3 US sales estimate of $9.49B, versus consensus of $9.56B.
09/12/17
MSCN
09/12/17
NO CHANGE
MSCN
McDonald's mentioned cautiously at MScience
09/08/17
BMOC
09/08/17
NO CHANGE
BMOC
Fast food restaurants more insulated from Amazon effects, says BMO Capital
BMO Capital says that fast food companies "are likely more insulated" from Amazon (AMZN) than other types of restaurants "due to their convenience-based usage occasions, low price points, and insulation from deflationary pressures." The firm identifies Wendy's (WEN) and McDonald's (MCD) as its favorite names in the fast food space.
WDC Western Digital
$88.78

1.4 (1.60%)

09/13/17
SBSH
09/13/17
NO CHANGE
Target $110
SBSH
Buy
Citi still sees Western Digital participating in Toshiba joint venture
Citi analyst Stanley Kovler says he continues to believe Western Digital (WDC) will be able to participate in the joint venture with Toshiba (TOSYY, TOSBF) and source NAND much like it has in the past, even after Toshiba signed a memorandum of understanding with the Bain Capital consortium for the sale of its memory business. If Western Digital takes a more commercial approach to resolution versus a legal route, the analyst sees a path to work with Bain and co-invest in Fab6. Kovler keeps a Buy rating on Western Digital with a $110 price target.
09/13/17
LBOW
09/13/17
NO CHANGE
Target $120
LBOW
Buy
iPhone 64GB starting point a 'pleasant surprise' for NAND makers, says Longbow
Longbow analyst Joe Wittine said many had expected a 32GB starting point for the memory in the new iPhones, consistent with the 7/7+, calling the new 64GB starting point for the iPhone 8/8+ a "pleasant surprise" for companies in the NAND supply chain. Rising NAND consumption could help smooth the eventual downside of the cycle for Western Digital, helping it maintain greater than 40% gross margins for longer, added the analyst. Wittine keeps a Buy rating and $120 price target on Western Digital shares.
09/12/17
RBCM
09/12/17
NO CHANGE
RBCM
Western Digital likely to hold minority stake in Toshiba, says RBC Capital
After Japanese newspaper Nikkan reported that a consortium which includes Western Digital (WDC) would buy Toshiba's (TOSBF) memory assets, RBC Capital analyst Amit Daryanani says that Western Digital will likely hold a minority stake in the assets, given anti-trust concerns. The analyst estimates that a 12%-13% stake would boost Western Digital's EPS by 25c-30c in 2018. Daryanani believes that the deal will be positive for the company as it will enable it to secure NAND bit capacity, prevent Foxconn/SK Hynix from getting the asset, and could boost its profits. He keeps a $115 price target and an Outperform rating on the stock.
09/11/17
JEFF
09/11/17
DOWNGRADE
JEFF
Hold
Seagate downgraded to Hold from Buy at Jefferies
Jefferies analyst James Kisner downgraded Seagate Technology (STX) to Hold after his channel checks indicated the company may still be struggling with the ramp of its 10TB helium drives. The analyst is also hearing about about potential increased price competition in nearline. He cut his price target for Seagate shares to $29 from $40. Kisner maintains a Hold rating on Seagate peer Western Digital (WDC).
CHK Chesapeake

05/11/17
BOFA
05/11/17
DOWNGRADE
Target $8
BOFA
Underperform
Chesapeake downgraded to Underperform, leverage too much, says BofA/Merrill
As previously reported, BofA/Merrill downgraded Chesapeake to Underperform from Neutral and lowered its price target to $8 from $11. Analysts led by Doug Leggate said oil markets are taking longer to recover and Chesapeake retains little upside from current strip prices and still has too much leverage if long-term oil and gas prices remain weak.
06/21/17
MACQ
06/21/17
DOWNGRADE
MACQ
Underperform
Chesapeake downgraded to Underperform from Neutral at Macquarie
Macquarie analyst Paul Grigel downgraded Chesapeake with a $3.50 price target citing increasing liquidity concerns against limited core inventory. The analyst does not expect a material portfolio improvement that will offset longer-term challenges.
09/05/17
TUDR
09/05/17
DOWNGRADE
TUDR
Hold
Chesapeake downgraded to Hold from Buy at Tudor Pickering
06/15/17
WOLF
06/15/17
INITIATION
Target $5.5
WOLF
Peer Perform
Chesapeake initiated with a Peer Perform at Wolfe Research
Wolfe Research initiated Chesapeake with a Peer Perform and a $5.50 price target.
AAPL Apple
$160.86

-0.64 (-0.40%)

09/13/17
CHLM
09/13/17
NO CHANGE
CHLM
Buy
Integrated Device to benefit from iPhone wireless charging, says Craig-Hallum
Craig-Hallum analyst Tony Stoss believes Integrated Device (IDTI) is positioned to benefit as the new Apple (AAPL) iPhone 8/8 Plus/X now all include Qi-based Wireless Charging and will be using at the launch WC pads from both Belkin and Mophie. While Integrated Device's wireless charging chip is not in the next generation iPhones, the analyst thinks its chip is included in both the Belkin and Mophie wireless charging pads. Stoss reiterates a Buy rating on Integrated Device's shares.
09/13/17
CHLM
09/13/17
NO CHANGE
CHLM
Iphone increasing band count positive for RF suppliers, says Craig-Hallum
Craig-Hallum analyst Tony Stoss notes that there are two new bands in the Apple (AAPL) iPhone 8/8 Plus /X in comparison to the iPhone 7. The analyst believes this is a positive for RF suppliers as increasing band count requires additional RF content per phone and believes total RF content is closer to $28 in the upcoming phones up from estimate of $26 for the iPhone 7. Stoss also believes RF suppliers are set up to benefit longer term as increasing band count, new technologies such as MIMO and CA will drive increased RF content per smartphone. The analyst reiterates a Buy rating on Skyworks (SWKS), Qorvo (QRVO) and Broadcom (AVGO).
09/13/17
CHLM
09/13/17
NO CHANGE
CHLM
Hold
Cirrus Logic likely to retain $6 content per Apple iPhone, says Craig-Hallum
Craig-Hallum analyst Tony Stoss notes Apple's (AAPL) next generation iPhones will continue to include the headphone adaptor in the box, which means Cirrus Logic (CRUS) will likely retain its $6 in content per iPhone. While the analyst believes this is a positive for Cirrus Logic given investor concerns the adaptor would not be included, he reiterates a Hold rating on the shares as he thinks Apple's iPhone coming in 2018 will likely not include an adaptor and it may be tough to keep content flat.
09/13/17
COWN
09/13/17
NO CHANGE
COWN
Apple supply chain read-through indicates unit growth in Q4, says Cowen
Cowen analyst Karl Ackerman said Apple's (AAPL) presentation was largely in line with expectations, but his supply chain work indicates a significant increase in iPhone X units for the December quarter. Based on his checks, companies with the most "interesting" read-through include Micron (MU), Teradyne (TER), Broadcom (AVGO), Qorvo (QRVO), Skyworks, (SWKS), and Universal Display (OLED), he tells investors.
M Macy's

06/07/17
GSCO
06/07/17
NO CHANGE
Target $25
GSCO
Neutral
Macy's price target lowered to $25 from $28 at Goldman Sachs
Goldman analyst Lindsay Drucker Mann lowerd Macy's price target to $25 from $28 to reflect weaker margin trends and operating earnings following the company's Investor Day. The analyst is encouraged by the detail around strategic initiatives and has confidence in -3-4% FY17 comp guidance range. Shares are Neutral rated.
09/06/17
COWN
09/06/17
NO CHANGE
Target $23
COWN
Market Perform
Macy's in early innings of leadership transformation, says Cowen
Cowen analyst Oliver Chen believes Macy's is in the early innings of a leadership transformation which he believes should drive increased speed, digital innovation/integration, and accelerated product differentiation. He also sees less negative comps in the second half of 2017 on a continuation of product initiatives and new marketing initiatives. Chen maintained his Market Perform rating and $23 price target on Macy''s shares.
08/11/17
UBSW
08/11/17
NO CHANGE
Target $21
UBSW
Neutral
Macy's Q2 better than feared, guidance hurts confidence, says UBS
UBS analyst Michael Binetti said Macy's reported Q2 results that were better than feared, but its second half guidance has damaged the confidence that its positive trends are sustainable. The analyst lowered his estimates and his price target to $21 from $23. Binetti maintained his Neutral rating on Macy's shares.
VALE Vale

09/12/17
SANT
09/12/17
UPGRADE
SANT
Buy
Vale upgraded to Buy from Hold at Santander
03/31/17
BMOC
03/31/17
UPGRADE
BMOC
Market Perform
Vale upgraded on higher iron ore price outlook at BMO Capital
As noted earlier, BMO Capital upgraded Vale to Market Perform from Underperform. Analyst Edward Sterck upgraded the stock based on an increase in his iron ore price outlook. Target to $10 from $7.
05/31/17
HSBC
05/31/17
UPGRADE
Target $10.5
HSBC
Buy
Vale upgraded to Buy from Hold at HSBC
HSBC analyst Jonathan Brandt upgraded Vale to Buy and raised his price target for the shares to $10.50 from $10. The recent decline in iron ore prices has mitigated risk, and the focus should now shift to the company's "strong" free cash flow generation and 6% dividend yield, Brandt tells investors in a research note.
05/31/17
05/31/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Donaldson (DCI) upgraded to Buy from Hold at Jefferies with analyst Laurence Alexander saying he sees "increasing evidence" the company's end-markets are exiting the multi-year trough and believes operating leverage should translate into above-average compound growth over the next few years. He recommends building positions in the stock during the second half of 2017. 2. VMware (VMW) upgraded to Outperform from Neutral at Baird with analyst Jason Noland citing the company's strategic shift to partner with firms rather than compete with the public cloud. 3. Akari Therapeutics (AKTX) upgraded to Neutral from Sell at Chardan. 4. Vale (VALE) upgraded to Buy from Hold at HSBC with analyst Jonathan Brandt saying the recent decline in iron ore prices has mitigated risk, and the focus should now shift to the company's "strong" free cash flow generation and 6% dividend yield. 5. Potbelly (PBPB) upgraded to Buy from Hold at Maxim with analyst Stephen Anderson citing news that Chief Executive Officer Aylwin Lewis is resigning, as he believes new management could reinvigorate performance. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

16:40
09/22/17
09/22
16:40
09/22/17
16:40
General news
Moody's downgrades UK's rating to Aa2, changes outlook to stable »

Moody's Investors…

A

Agilent

$65.78

-0.14 (-0.21%)

, MRK

Merck

$65.13

-0.47 (-0.72%)

16:36
09/22/17
09/22
16:36
09/22/17
16:36
Hot Stocks
Agilent receives expanded FDA approval for the use of Dako PD-L1 IHC 22C3 »

Agilent Technologies…

A

Agilent

$65.78

-0.14 (-0.21%)

MRK

Merck

$65.13

-0.47 (-0.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 26

    Sep

  • 08

    Nov

  • 30

    Nov

TYHT

Shineco

$3.23

-0.45 (-12.23%)

16:35
09/22/17
09/22
16:35
09/22/17
16:35
Hot Stocks
Shineco enters into strategic cooperation to establish Apocynum Industrial Park »

Shineco announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARCI

Appliance Recycling

$1.16

0.03 (2.65%)

16:34
09/22/17
09/22
16:34
09/22/17
16:34
Hot Stocks
Appliance Recycling gets written notice of default »

On September 20,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RNVA

Rennova Health

$0.22

0.0086 (4.07%)

16:31
09/22/17
09/22
16:31
09/22/17
16:31
Hot Stocks
Rennova Health announces 1 for 15 reverse stock split »

Rennova Health announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARCI

Appliance Recycling

$1.16

0.03 (2.65%)

16:31
09/22/17
09/22
16:31
09/22/17
16:31
Hot Stocks
Breaking Hot Stocks news story on Appliance Recycling »

Appliance Recycling gets…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
09/22/17
09/22
16:30
09/22/17
16:30
Options
Preliminary option volume of 13.9M today »

Preliminary option volume…

EKSO

Ekso Bionics

$1.28

0.14 (12.28%)

16:23
09/22/17
09/22
16:23
09/22/17
16:23
Hot Stocks
Ekso Bionics awarded government contract »

The Department of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNH

UnitedHealth

$193.03

-2.18 (-1.12%)

, AET

Aetna

$153.57

0.18 (0.12%)

16:22
09/22/17
09/22
16:22
09/22/17
16:22
General news
On The Fly: Top stock stories for Friday »

The major averages…

UNH

UnitedHealth

$193.03

-2.18 (-1.12%)

AET

Aetna

$153.57

0.18 (0.12%)

ANTM

Anthem

$182.86

-0.64 (-0.35%)

CI

Cigna

$182.74

0.61 (0.33%)

AAPL

Apple

$151.89

-1.5 (-0.98%)

FSLR

First Solar

$51.41

2.65 (5.43%)

FINL

Finish Line

$9.73

0.51 (5.53%)

ASND

Ascendis Pharma

$34.24

6.5 (23.43%)

VSAR

Versartis

$2.68

-18.925 (-87.62%)

ICPT

Intercept

$61.59

-12.11 (-16.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 22

    Oct

DLR

Digital Realty

$114.51

-1.72 (-1.48%)

16:19
09/22/17
09/22
16:19
09/22/17
16:19
Syndicate
Breaking Syndicate news story on Digital Realty »

Digital Realty files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

16:17
09/22/17
09/22
16:17
09/22/17
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSS

TSYS

$69.09

0.28 (0.41%)

16:16
09/22/17
09/22
16:16
09/22/17
16:16
Hot Stocks
TSYS announces resignation of COO Pamela Joseph »

TSYS announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

16:16
09/22/17
09/22
16:16
09/22/17
16:16
Technical Analysis
NYSE market internals summary »

Volume was below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$170.54

-0.57 (-0.33%)

16:15
09/22/17
09/22
16:15
09/22/17
16:15
Hot Stocks
Facebook's Zuckerberg plans to sell up to 75M shares to fund charity initiatives »

On September 22 Mr.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

IDA

IDACORP

$87.79

-0.73 (-0.82%)

16:13
09/22/17
09/22
16:13
09/22/17
16:13
Hot Stocks
IDACORP raises quarterly dividend 7.3% to 59c per share »

The dividend declaration,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLRX

Valeritas

$3.06

-0.23 (-6.99%)

16:13
09/22/17
09/22
16:13
09/22/17
16:13
Syndicate
Valeritas announces common stock purchase agreement by Aspire Capital »

Valeritas Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$170.54

-0.57 (-0.33%)

16:12
09/22/17
09/22
16:12
09/22/17
16:12
Hot Stocks
Facebook dumps plan for new class of shares »

On September 21 the board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

DCIX

Diana Containerships

$0.42

-0.0373 (-8.16%)

16:11
09/22/17
09/22
16:11
09/22/17
16:11
Hot Stocks
Diana Containerships announces one-for-three reverse stock split »

Diana Containerships…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEP

Spectra Energy Partners

$43.89

0.34 (0.78%)

16:10
09/22/17
09/22
16:10
09/22/17
16:10
Syndicate
Breaking Syndicate news story on Spectra Energy Partners »

Spectra Energy Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEV

Sevcon

$22.04

0.04 (0.18%)

, BWA

BorgWarner

$50.00

0.41 (0.83%)

16:10
09/22/17
09/22
16:10
09/22/17
16:10
Hot Stocks
Sevcon stockholders approve acquisition by BorgWarner »

Sevcon (SEV) announced…

SEV

Sevcon

$22.04

0.04 (0.18%)

BWA

BorgWarner

$50.00

0.41 (0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 26

    Oct

ATOS

Atossa Genetics

$0.49

-0.0296 (-5.71%)

16:07
09/22/17
09/22
16:07
09/22/17
16:07
Syndicate
Breaking Syndicate news story on Atossa Genetics  »

Atossa Genetics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CB

Chubb

$142.68

-0.27 (-0.19%)

16:06
09/22/17
09/22
16:06
09/22/17
16:06
Hot Stocks
Chubb CEO issues statement on EU-U.S. covered agreement »

Evan Greenberg, Chairman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 31

    Jan

AAPL

Apple

$153.39

-2.68 (-1.72%)

15:40
09/22/17
09/22
15:40
09/22/17
15:40
Options
Active trading in Apple as iPhone 8 makes a debut »

Active trading in Apple…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

MRK

Merck

15:39
09/22/17
09/22
15:39
09/22/17
15:39
Hot Stocks
Merck gets FDA approval for Keytruda »

Merck announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 26

    Sep

  • 08

    Nov

  • 30

    Nov

TAL

TAL Education

$33.09

-0.45 (-1.34%)

15:35
09/22/17
09/22
15:35
09/22/17
15:35
Options
Tal Education Group put volume heavy and directionally bearish »

Bearish flow noted in Tal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.